Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 19

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 19
---
| •Other than the Chair/CEO, all directors are independent                                                   
 •Lead Independent Director with clearly defined responsibilities                                           
 •100% independent Audit, Compliance, Corporate Governance, Finance, and People Resources Committees        
 •Regular meetings of the independent directors of the Board and its committees, without management present 
 •Board and its committees may hire outside advisors independently of management                            |     | •Active shareholder engagement                                                                                                         
 •Diverse Board in terms of experiences, specific skills and qualifications, tenure, gender, race, ethnicity, abilities and backgrounds 
 •Board policy to ensure individuals from underrepresented backgrounds included in candidate pool for all director searches             
 •Separate Code of Business Conduct and Ethics for the Board                                                                            
 •Majority of director compensation delivered in common stock of The Cigna Group                                                        
 •Robust stock ownership guidelines for directors                                                                                       |     | •Annual election of all directors                                                                                                                     
 •Directors elected by majority vote standard for uncontested election                                                                                 
 •Annual self-evaluations of the Board, its committees, and individual directors, which, in 2024, included a third-party facilitator and peer feedback 
 •Annual evaluation of the Board leadership structure                                                                                                  
 •Annual evaluation of CEO (including compensation) by independent directors                                                                           
 •Clawback policies that comply with and go beyond the requirements of the Dodd-Frank Act and NYSE rules                                               |     | •Shareholder right to call a special meeting                                                                                                                         
 •Proxy access right allowing shareholders to include their nominees in proxy materials for election at annual meetings                                               
 •Shareholder right to amend our Certificate of Incorporation or By-Laws with support of holders of a majority of outstanding stock; no supermajority vote provisions 
 •No shareholder rights plan or poison pill                                                                                                                           |

| 28 |     | The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |

| CORPORATE GOVERNANCE MATTERS |

#### Director Independence
The Cigna Group believes in the importance of a board composed primarily of independent, non-employee directors. Eleven of the twelve directors on the current Board are non-employee directors. On an annual basis, the Board, through its Corporate Governance Committee, reviews relevant relationships between directors, their immediate family members, and the Company, consistent with the independence standards of The Cigna Group. These independence standards, which are included in the Guidelines, are consistent with the independence requirements set forth in the NYSE’s listing standards.

To be independent, the Board must affirmatively